Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of eudesmane sesquiterpene lactone epimers in preparation of anti-breast cancer medicine

A technology of sesquiterpene lactones and epimers, which is applied in the field of chemistry and can solve unsolved problems such as the determination of the absolute configuration of epimers

Inactive Publication Date: 2020-05-22
HAINAN NORMAL UNIV
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the determination of the absolute configuration of the epimer has not been resolved, and there have been no reports on anti-tumor activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of eudesmane sesquiterpene lactone epimers in preparation of anti-breast cancer medicine
  • Application of eudesmane sesquiterpene lactone epimers in preparation of anti-breast cancer medicine
  • Application of eudesmane sesquiterpene lactone epimers in preparation of anti-breast cancer medicine

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0028] Example 1 Eucalyptane-type sesquiterpene lactone epimer anti-breast cancer cell MCF-7 activity test

[0029] 1. Experimental method: the breast tumor cell line MCF-7 was incubated with RPMI-1640 medium containing 10% calf serum at 37°C and 5% CO 2 cultured in an incubator. The MTT method was used to carry out the cell proliferation inhibition test. The main operation was to take the tumor cell lines in the logarithmic growth phase, digest them with 0.25% trypsin, and prepare 5×10 RPMI-1640 culture medium with 10% newborn calf serum. 4 pcs / ml -1 The cell suspension was inoculated in a 96-well plate with 180 μL per well. At 37°C, 5% CO 2 Cultivate for 8-10 hours under saturated humidity conditions, and when they adhere to the wall, add sample solution prepared with PBS to each well so that the final concentrations of the samples are 1, 10 and 100 μg / mL, respectively. For each concentration, 3 wells were paralleled, and after 44 hours of continuous culture, 50 μL MTT (...

Embodiment 2

[0035] Example 2 Observation of Sesquiterpene Lactone Epimer-Induced Morphological Changes in Breast Cancer Cell MCF-7 Cells under an Inverted Microscope

[0036] 1. Experimental method: Take the breast cancer cell MCF-7 in the logarithmic growth phase and press 1×10 6 cells / mL were inoculated into 6-well culture plates. The sample to be tested was dissolved in 0.1% DMSO to prepare a storage solution. Compounds 1 and 2 at the same concentration (10 μg / ml) were added to each administration group, and an equal volume of culture solution containing 0.1% DMSO was added to the vehicle control group. After culturing for 24 h, the morphological changes of the cells were observed and photographed under an inverted microscope. Such as figure 1 As shown, the effects of compounds 1 and 2 on the morphology of breast cancer cell MCF-7 were observed under an inverted microscope.

[0037] 2. Explanation of the experimental results: After 24 hours of drug treatment, the compound 2 group c...

Embodiment 3

[0038] Example 3 Detection of the level of reactive oxygen species ROS in breast cancer MCF7 cells

[0039] Add 3 × 10 per well in a six-well plate 5 MCF-7 cells with logarithmic growth were cultured for 24 hours, and culture medium with a concentration of 10 μg / mL of the sample to be tested was added and cultured for 36 hours, and then the fluorescent probe DCFH-DA was used to detect reactive oxygen species ROS. Add 1 mL of diluted DCFH-DA to each well, incubate at 37°C for 20 min in a cell culture incubator, wash the basal medium three times, and measure ROS levels by fluorescence intensity under an inverted fluorescence microscope. Or digest the cells, suspend in DCFH-DA solution with a final concentration of 10 μmol / L, incubate at 37° C. for 20 minutes in a cell incubator, and wash three times. The ROS content was detected by flow cytometry, the excitation wavelength was 502nm, the emission wavelength was 530nm, and the data was analyzed by FlowJo software. Experiments w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pair of eudesmane sesquiterpene lactone epimers (1S,4S,5S,6S,7S,8S,9R,10S)-1,9-diacetoxy-4-hydroxy-6-isobutyryloxyprostatolide and (1S,4S,5R,6S,7S,8S,9R,10S)-1,9-diacetoxy-4-hydroxyl-6-isobutyryloxyprostatolide, pharmaceutically acceptable salts or solvates of the epimers, and pharmacodynamic activity of a pharmaceutical composition composed of the compounds, and mainly relates to a medical application of an anti-breast cancer medicine in inducing breast cancer cell MCF-7 cell morphology to retract and become round and the level of intracellular reactive oxygen species (ROS) to rise to show tumor cytotoxicity.

Description

technical field [0001] The invention belongs to the field of chemistry, and relates to a pair of epimers of eucalyptus-type sesquiterpene lactones, their pharmaceutically acceptable salts or solvates, and the pharmacodynamic activity of the pharmaceutical composition formed therefrom, in particular to their induction of breast cancer The medical use of the cell MCF-7 showing cytotoxic activity due to the retraction and rounding of the cell shape and the increase of the intracellular reactive oxygen species (ROS) level. Background technique [0002] Breast cancer is the most common cancer in women and mainly includes ductal and lobular carcinomas. The incidence of breast cancer ranks first among female malignant tumors, and its mortality rate ranks second. According to the data report of breast cancer in my country in 2018, the number of female breast cancer cases and deaths in my country accounted for 11.2% and 9.2% of the global incidence and death respectively. , ranks in ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/365A61P15/14A61P35/00
CPCA61K31/365A61P15/14A61P35/00
Inventor 陈文豪惠阳戴春燕周秀悄
Owner HAINAN NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com